Evercore ISI Reaffirms Their Buy Rating on Enovis (ENOV)

Evercore ISI analyst Vijay Kumar maintained a Buy rating on Enovis today and set a price target of $44.00. The company’s shares opened today at $31.22.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Kumar covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Agilent, and Azenta. According to TipRanks, Kumar has an average return of 1.3% and a 49.45% success rate on recommended stocks.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Enovis with a $48.75 average price target.

ENOV market cap is currently $1.79B and has a P/E ratio of -2.11.

Based on the recent corporate insider activity of 64 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ENOV in relation to earlier this year. Last month, Damien McDonald, the CEO of ENOV bought 6,457.00 shares for a total of $199,973.29.